Skip to content

TO SEE THE EFFECT OF KSHARA GUDIKA ORALLY AND PANCHATIKTA GHRITA UTTARBASTI PROCEDURE IN THE MANAGEMENT OF GARBHASYA ARBUDA W.S.R UTERINE FIBROID

A RANDOMIZED OPEN LABELLED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF KSHARA GUDIKA AND PANCHATIKTA GHRITA UTTARBASTI IN THE MANAGEMENT OF GARBHASYA ARBUDA W.S.R UTERINE FIBROID - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077505
Enrollment
60
Registered
2024-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N858- Other specified noninflammatory disorders of uterus

Interventions

None listed

Sponsors

INSTITUTE FOR AYURVED STUDIES AND RESEARCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having uterine fibroid size less than or equal to 5cm as per USG report, Single/Multiple fibroids. Patient either asymptomatic or having clinical signs and symptoms of uterine fibroid. Patient willing to participate in trial.

Exclusion criteria

Exclusion criteria: Patient below age 20 years & above age 50 years. Patient having fibroid size more than 5cm as per USG report. Pregnancy, Unmarried, Post-Menopausal, Ovarian tumor, Tubo-ovarian mass, any Malignant tumor, sarcomatous changes in fibroid, fibroid with adenomyosis. Patient with BMI less than 18.5/ Hyperacidity/ Ulcers (for oral drug). Patient with HTN, TB, Uncontrolled DM and any other severe systemic diseases.

Design outcomes

Primary

MeasureTime frame
To resolve or reduce the size of Uterine Fibroid. To improve the signs and symptoms associated with uterine fibroid.Timepoint: To resolve or reduce the size of Uterine Fibroid reviewed on 30,60,90 days To improve the signs and symptoms associated with uterine fibroid reviewed on 30,60,90 days

Secondary

MeasureTime frame
Changes in other associated clinical features related to uterine fibroid.Timepoint: Follow up for subjective criteria after every 1 month. Follow up for objective criteria after every 1 month.

Countries

India

Contacts

Public ContactDR PINKI

INSTITUTE FOR AYURVED STUDIES AND RESEARCH

drsunititanwar@gmail.com9996311778

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026